Literature DB >> 18322984

Autoantibody to signal recognition particle in African American girls with juvenile polymyositis.

Kelly A Rouster-Stevens1, Lauren M Pachman.   

Abstract

Anti-signal recognition particle (anti-SRP) is a myositis-specific autoantibody that is linked to a severe polymyositis (PM) associated with interstitial lung disease (ILD) and esophageal dysmotility in adults. We describe 3 African American adolescent girls with anti-SRP juvenile PM. One child required aggressive treatment to control her disease and 2 were refractory to multiple immunosuppressants. Patient 1 developed ILD and cardiac disease; Patient 2 developed ILD; Patient 3 developed esophageal dysmotility and cardiac disease. Organ system involvement was comparable to that seen in adults. We conclude that testing for anti-SRP in children with PM may facilitate diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322984

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

Review 1.  Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; James D Katz; Olcay Y Jones
Journal:  Rheum Dis Clin North Am       Date:  2013-09-19       Impact factor: 2.670

Review 2.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

Review 3.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

Review 4.  Use of Rescue Therapy with IVIG or Cyclophosphamide in Juvenile Myositis.

Authors:  Theonymfi Doudouliaki; Charalampia Papadopoulou; Claire T Deakin
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592

5.  Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.

Authors:  Altaf Hussain; Amit Rawat; Ankur Kumar Jindal; Anju Gupta; Surjit Singh
Journal:  Rheumatol Int       Date:  2017-03-22       Impact factor: 2.631

Review 6.  Immune-mediated necrotizing myopathy.

Authors:  C Bergua; H Chiavelli; J P Simon; O Boyer; F Jouen; W Stenzel; J Martinet
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 7.  Advances in biomarkers for paediatric rheumatic diseases.

Authors:  Alessandro Consolaro; Giulia C Varnier; Alberto Martini; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2014-12-16       Impact factor: 20.543

8.  Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP).

Authors:  Felix Wantke; Meinhard Kneussl; Marianne Hubner; Kurt Derfler; Thomas Brücke; Sabine Schmaldienst
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

Review 9.  The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.

Authors:  L G Rider; K Nistala
Journal:  J Intern Med       Date:  2016-03-30       Impact factor: 8.989

10.  Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

Authors:  H Gunawardena; L R Wedderburn; H Chinoy; Z E Betteridge; J North; W E R Ollier; R G Cooper; C V Oddis; A V Ramanan; J E Davidson; N J McHugh
Journal:  Arthritis Rheum       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.